Israel’s biotechnology investment hub
Clal Biotechnology Industries is a leading life sciences investment company traded on the Tel Aviv stock exchange (TASE: CBI). CBI is focused on identifying and supporting promising innovative ventures, developing proprietary solutions and addressing unmet medical needs with significant market potential.
With offices in Tel-Aviv and Boston, we provide our portfolio companies access to the global biotechnology industry.
Based on top Israeli science, our portfolio companies ranging from seed to maturity, both public and private. We apply diverse models of strategic cooperation, providing hands-on leadership and guidance.
Empowering life sciences solutions
CBI’s investments range from biotech and pharma to diagnostics and medical devices.
Our team maximizes the value of existing investments, contributes to the development of investee companies and finds new investments and business opportunities in Israel and the United States with high potential return globally.
Clal Industries Ltd. is one of Israel’s leading investment companies. It holds a portfolio of investments from heavy industry to biotechnology, hi-tech and energy companies. Clal Industries is fully owned by Access Industries, a privately held industrial group with long-term holdings worldwide.
Access Industries is a privately-held industrial group with long-term holdings worldwide. Founded in 1986 by British-American industrialist and philanthropist Len Blavatnik, Access identifies new strategic investment opportunities and invests in both emerging and established industries to create transformative companies and generate significant growth over time. Headquartered in the United States, Access owns strategic and diversified investments around the world in various key sectors including media and telecommunications, natural resources and chemicals, venture capital, real estate and biotechnology.